Audentes Therapeutics, Inc
BOLD
BOLD was delisted on the 14th of January, 2020.
58 hedge funds and large institutions have $272M invested in Audentes Therapeutics, Inc in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
2% more funds holding
Funds holding: 57 → 58 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less capital invested
Capital invested by funds: $283M → $272M (-$10.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$13.9M |
| 2 |
CC
Casdin Capital
New York
|
+$4.21M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.76M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$728K |
| 5 |
SIM
Spark Investment Management
New York
|
+$448K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$748K |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$404K |
| 3 |
RI
RTW Investments
New York
|
-$365K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$307K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$294K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Legal & General Group
London,
United Kingdom
| $18K | – | – | – |
|
|
AIP
52
Ameritas Investment Partners
Lincoln,
Nebraska
| $7K | +$6.6K | +408 | New |
|
53
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | -$32 | -2 | -0.7% |
|
54
BNP Paribas Financial Markets
Paris,
France
| $4.5K | +$2.2K | +136 | +106% |
|
55
Citigroup
New York
| $3K | +$2.41K | +149 | +3,725% |
|
|
TRCT
56
Tower Research Capital (TRC)
New York
| $2K | -$5.05K | -312 | -76% |
|
|
MAM
57
Meeder Asset Management
Dublin,
Ohio
| $2K | +$2.12K | +131 | New |
|
|
RI
58
RTW Investments
New York
| – | -$365K | -20,000 | Closed |
|
59
SG Americas Securities
New York
| – | -$138K | -7,569 | Closed |
|
60
UBS Group
Zurich,
Switzerland
| – | +$275 | +17 | New |
|
BOLD Hedge Fund Activity: Q1 2017 in Review
58 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Audentes Therapeutics, Inc (BOLD) for Q1 2017, worth a combined $272M — down 3.8% from $283M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BOLD positions and 2 closed out — a net gain of 7 holders — while 19 added to existing stakes and 15 trimmed.
The largest buyer was BlackRock, adding an estimated $13.9M. The largest seller was AllianceBernstein, cutting an estimated $748K.
- 58 institutional investors held Audentes Therapeutics, Inc (BOLD) as of Q1 2017, up from 57 in Q4 2016.
- Funds reported $272M of Audentes Therapeutics, Inc stock for Q1 2017, down 3.8% quarter-over-quarter.
- 9 funds opened new Audentes Therapeutics, Inc positions in Q1 2017 and 2 closed out, a net change of +7 holders.
- The largest Audentes Therapeutics, Inc buyer in Q1 2017 was BlackRock, an estimated $13.9M added.
- The largest Audentes Therapeutics, Inc seller in Q1 2017 was AllianceBernstein, an estimated $748K sold.
Based on aggregated 13F filings for Q1 2017.